Commentary

Advisors are likely to widen their scope of deal type this year amid the pause in traditional LP sales and GP-led processes.

The growth of the secondaries market has halted, though certain segments remain open to LPs and GPs, according to Andrew Gulotta of Sixpoint Partners and DLA Piper's Adam Tope.

Widespread deal syndication could give rise to unanticipated problems amid the coronavirus crisis.

The co-head of the $53bn investment manager's secondaries team discusses its $2.1bn fundraise and how it plans to navigate the coronavirus crisis.

GPs have options when their funds are coming to an end, though they're not a walk in the park, writes Bruno Alves of sister title Infrastructure Investor.

Compared with 2008, the secondaries market is better positioned for a swift recovery, writes Triago managing partner Mathiéu Drean.

While the covid-19 story has a long way to run, several important themes have started to emerge.

Staffan Mörndal, a partner who leads the firm's Germany operations, says he has seen many 'strange effects' of the covid-19 crisis.

We caused a stir with reports of unnamed LP defaults last week; was it a storm in a teacup?

GP-led processes were used to isolate top performing assets during the bull market, so why not the opposite now?